Erschienen in:
01.07.2014 | Editorial
Salvage surgery for head and neck squamous cell carcinoma
verfasst von:
Magis Mandapathil, Marion Roessler, Jochen A. Werner, Carl E. Silver, Alessandra Rinaldo, Alfio Ferlito
Erschienen in:
European Archives of Oto-Rhino-Laryngology
|
Ausgabe 7/2014
Einloggen, um Zugang zu erhalten
Excerpt
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and fifth most frequent cause of malignancy-related mortality [
1,
2]. Despite advances in various treatment modalities, the overall prognosis of HNSCC patients has not improved significantly within the last several decades. About 50 % of patients survive their disease [
3]. Advanced tumors have a recurrence rate of around 20–30 % at the primary tumor site and 10–15 % in the neck [
3]. …